Ironwood Pharmaceuticals (IRWD) Times Interest Earned (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Times Interest Earned data on file, last reported at $7.94 in Q1 2026.

• For the quarter ending Q1 2026, Times Interest Earned rose 320.11% year-over-year to $7.94; the trailing twelve-month figure through Mar 2026 stood at $6.37 (down 32.09% YoY), and the FY2025 full-year result was $0.78, down 11.0% from the prior year.
• Times Interest Earned rose to $7.94 in Q1 2026, from $1.24 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $44.93 in Q3 2022 to a low of -$588.66 in Q2 2023.
• A 5-year average of -$37.05 and a median of $3.69 in 2023 frame the typical range for Times Interest Earned.
• Peak annual rise in Times Interest Earned reached 440.57% in 2022, while the deepest fall reached 3037.24% in 2022.
• Tracing IRWD's Times Interest Earned over 5 years: stood at -$209.06 in 2022, then soared by 101.77% to $3.69 in 2023, then tumbled by 144.15% to -$1.63 in 2024, then surged by 176.25% to $1.24 in 2025, then jumped by 538.53% to $7.94 in 2026.
• Business Quant data shows IRWD's Times Interest Earned at $7.94 in Q1 2026, $1.24 in Q4 2025, and $8.95 in Q3 2025.